Brave Asset Management’s CRISPR Therapeutics CRSP Stock Holding History

Brave Asset Management’s Portfolio CRSP Stock Details CRSP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-16,700	Closed	-$794K	–	148
2026 Q1	$794K	Buy	16,700 +4,300	+35%	+$227K	0.19%	58
2025 Q4	$650K	Sell	12,400 -2,000	-14%	-$120K	0.15%	66
2025 Q3	$933K	Buy	14,400 +400	+3%	+$23K	0.23%	49
2025 Q2	$681K	Buy	14,000 +10,500	+300%	+$406K	0.19%	63
2025 Q1	$119K	Buy	3,500 +1,000	+40%	+$42.4K	0.04%	140
2024 Q4	$98.4K	Buy	+2,500	New	+$118K	0.03%	141
2024 Q3	–	Sell	-700	Closed	-$37.8K	–	172
2024 Q2	$37.8K	Hold	700	–	–	0.01%	146
2024 Q1	$47.7K	Sell	700 -4,600	-87%	-$329K	0.01%	150
2023 Q4	$332K	Buy	5,300 +3,300	+165%	+$182K	0.09%	94
2023 Q3	$90.8K	Hold	2,000	–	–	0.03%	131
2023 Q2	$112K	Hold	2,000	–	–	0.03%	131
2023 Q1	$90.5K	Buy	+2,000	New	+$97.1K	0.03%	135

Other funds holding CRSP

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Wealth Enhancement Trust Services Sioux Falls, South Dakota $792M AUM

Handelsbanken Fonder

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

Wealth Enhancement Advisory Services

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.6B AUM 29.42% 1-Year Est. Return

180 Wealth Advisors Federal Way, Washington $997M AUM 47.84% 1-Year Est. Return

SteelPeak Wealth Woodland Hills, California $3.8B AUM 48.92% 1-Year Est. Return

Independent Financial Group San Diego, California $5.35B AUM 43.78% 1-Year Est. Return

IVC Wealth Advisors Silverdale, Pennsylvania $256M AUM 27.59% 1-Year Est. Return

PSP Research Newtown Square, Pennsylvania $188M AUM